Trials / Conditions / Multiple Myleoma
Multiple Myleoma
6 registered clinical trials studyying Multiple Myleoma — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Teclistamab Plus Autologous Lymphocyte Infusion (ALI) for the Treatment of R/R Multiple Myeloma NCT06880601 | Gruppo Italiano Malattie EMatologiche dell'Adulto | Phase 2 |
| Recruiting | Universal CAR-T Cells (REVO-UWD-00B) for Refractory and Relapsed Multiple Myeloma NCT06663046 | Wondercel Biotech (ShenZhen) | EARLY_Phase 1 |
| Recruiting | GR1803 Injection in Patients With RRMM NCT06952075 | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | Phase 2 |
| Recruiting | A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+ NCT05645107 | Grifols Therapeutics LLC | Phase 3 |
| Completed | Study of Lymphoma in Asia NCT01584141 | National Cancer Institute (NCI) | — |
| Terminated | Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to T NCT00074490 | National Cancer Institute (NCI) | Phase 2 |